Revenue: The sum of all revenue fields included for a company's operating activities.
Oncobiologics, Inc. (OTLK) had Revenue of $-0.09M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
|
Revenue |
$-0.09M |
$-13.29M |
|
$0.92M |
|
$-1.01M |
|
$17.22M |
|
$-17.31M |
|
$2.47M |
|
$-14.85M |
|
$-14.85M |
|
$-13.29M |
|
$-13.29M |
|
$-13.29M |
|
$-13.29M |
|
$-17.31M |
|
$-17.28M |
|
34.80M |
|
34.80M |
|
$-0.46 |
|
$-0.46 |
|
| Balance Sheet Financials | |
$17.39M |
|
-- |
|
$1.20M |
|
$18.58M |
|
$45.81M |
|
-- |
|
$4.96M |
|
$50.77M |
|
$-32.19M |
|
$-32.19M |
|
$-32.19M |
|
53.89M |
|
| Cash Flow Statement Financials | |
$-51.83M |
|
-- |
|
$44.98M |
|
$14.93M |
|
$8.08M |
|
$-6.84M |
|
$8.90M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.38 |
|
-- |
|
-- |
|
-- |
|
-0.93 |
|
1098.52% |
|
18863.91% |
|
18863.90% |
|
-- |
|
16175.93% |
|
14482.20% |
|
$-51.83M |
|
-- |
|
-- |
|
-- |
|
-0.00 |
|
0.27 |
|
-0.06 |
|
-1461.90 |
|
41.30% |
|
41.30% |
|
-71.53% |
|
41.30% |
|
$-0.60 |
|
$-1.49 |
|
$-1.49 |
|